Jha told reporters that the US government had enough COVID-19 vaccines from Pfizer Inc and Moderna Inc to begin the programme for young children if and when the vaccines are approved.
Pfizer and its partner BioNTech on Wednesday completed their filing with the US Food and Drug Administration to seek authorisation for their COVID-19 vaccine in young children.It remains unclear how many parents will get their young ones vaccinated as demand has been low in kids aged 5 to 11. The FDA’s independent advisers will discuss the two applications in a meeting set for June 14-15, with the FDA expected to make a decision shortly thereafter, Jha said.
Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше: